DBV Technologies
Develops epicutaneous immunotherapy (EPIT) patch technology for food allergies.
DBV | PA
Overview
Corporate Details
- ISIN(s):
- FR0010417345 (+3 more)
- LEI:
- 969500PVBQFWQKVDMD80
- Country:
- France
- Address:
- 107 AVENUE DE LA REPUBLIQUE, 92320 CHATILLON
- Sector:
- Manufacturing
Description
DBV Technologies is a clinical-stage biopharmaceutical company developing treatments for food allergies and other immunological diseases. The company's core technology is Viaskin®, a proprietary investigational platform based on epicutaneous immunotherapy (EPIT). This non-invasive patch technology is designed to re-educate the immune system by delivering minimal amounts of antigens through intact skin. DBV's lead product candidate, Viaskin Peanut (DBV712), is in late-stage clinical development for the treatment of peanut allergies in pediatric patients. The development pipeline also includes Viaskin Milk (DBV135) for milk allergies, with the platform holding potential for applications beyond food allergies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-05-17 22:30 |
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 96.8 KB | ||
| 2021-05-05 23:00 |
DBV Technologies Announces Filing of its First Form 10-Q for the First Quarter …
|
English | 145.2 KB | ||
| 2021-05-03 07:30 |
DBV Technologies annonce ses résultats financiers du premier trimestre 2021
|
French | 283.8 KB | ||
| 2021-05-03 07:30 |
DBV Technologies Reports Q1 2021 Financial Results
|
English | 276.3 KB | ||
| 2021-04-29 07:30 |
DBV Technologies invitée à participer aux prochaines conférences Investisseurs
|
French | 146.6 KB | ||
| 2021-04-29 07:30 |
DBV Technologies to Participate in Upcoming Investor Conferences
|
English | 102.6 KB | ||
| 2021-04-28 22:30 |
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 97.6 KB | ||
| 2021-04-28 22:30 |
Monthly information regarding the total number of voting rights and total numbe…
|
English | 87.9 KB | ||
| 2021-04-28 07:30 |
Ordinary and Extraordinary General Meeting of May 19, 2021 to be Held in Closed…
|
English | 156.5 KB | ||
| 2021-04-28 07:30 |
L’Assemblée Générale Mixte du 19 mai 2021 se tiendra à huis-clos en raison de l…
|
French | 150.8 KB | ||
| 2021-04-02 22:30 |
DBV Technologies annonce la nomination de Timothy E. Morris au conseil d'admini…
|
French | 198.9 KB | ||
| 2021-04-02 22:30 |
DBV Technologies Announces Appointment of Timothy E. Morris to Board of Directo…
|
English | 153.3 KB | ||
| 2021-04-02 00:30 |
Information mensuelle relative au nombre total des droits de vote et d’actions …
|
French | 96.8 KB | ||
| 2021-04-02 00:30 |
Monthly information regarding the total number of voting rights and total numbe…
|
English | 160.4 KB | ||
| 2021-03-17 23:30 |
DBV Technologies Publie son « Form 10-K » américain et son Document d’Enregistr…
|
French | 246.4 KB |
Automate Your Workflow. Get a real-time feed of all DBV Technologies filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for DBV Technologies
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for DBV Technologies via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-06-09 | N/A | Other | Other | 2,483,161 | 7,449,483.00 EUR |
Peer Companies
